Chimeric Antigen Receptor (CAR) T-CEll Therapy

Dr Siok Tey and TRI-based Mater Research's Prof John Hooper will talk to us about their collaboration in generating gene-modified immune cells generated in-house. 

Dr Tey is a consultant haematologist and bone marrow transplant physician at Royal Brisbane and Women’s Hospital; and laboratory head at QIMR Berghofer. She received her medical and haematology training in Brisbane, followed by a research fellowship at the Center for Cell and Gene Therapy at Baylor College of Medicine, Houston, USA. She completed a PhD in T cell immunity and a post-doctorate in experimental bone marrow transplantation, both at QIMR Berghofer.  She initiated one of the first investigator-led clinical trials in Australia that used in-house manufactured gene-modified T cells in 2014.  She is academic lead of the cell therapy research program at RBWH and Medical Director of the Good Manufacturing Practice Facility at QIMR Berghofer. Her research interests are bone marrow transplantation, cellular immunology and the development of novel cellular immunotherapeutics from first principles through to early phase clinical trials.

No recording available due to commercial confidentiality.